Isaac Nofrerias

Isaac Nofrerias

Auto-generated profile, based on publicly available information

Isaac Nofrerias

Pharmacy and Pharmaceutical Technology, and Physical Chemistry Department, Faculty of Pharmacy and Food Sciences, University of Barcelona, Avda. Joan XXIII s/n, 08028, Barcelona, Spain.

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2019 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
INIsaac Nofrerias
Isaac Nofrerias
ANAnna Nardi
Anna Nardi
MSMarc Suñé-Pou
Marc Suñé-Pou
JSJosep M. Suñé-Negre
Josep M. Suñé-Negre
EGEncarna García-Montoya
Encarna García-Montoya
JTJosep R. Ticó
Josep R. Ticó

1 November 2015 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
NTNicolas Tarlier
Nicolas Tarlier
ISIan Soulairol
Ian Soulairol
BBBernard Bataille
Bernard Bataille
GBGilles Baylac
Gilles Baylac
PRPatrice Ravel
Patrice Ravel
TSTahmer Sharkawi
Tahmer Sharkawi

1 January 2019 in Powder Technology
Verified
Journal Article
Closed access
INIsaac Nofrerias
Isaac Nofrerias
ANAnna Nardi
Anna Nardi
MSMarc Suñé-Pou
Marc Suñé-Pou
Josep Suñé-NegreJosep Suñé-Negre
Josep Suñé-Negre
EGEncarna García-Montoya
Encarna García-Montoya
MMMontserrat Miñarro
Montserrat Miñarro

1 May 2018 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
MSMarc Suñé-Pou
Marc Suñé-Pou
SPSilvia Prieto-Sánchez
Silvia Prieto-Sánchez
YYYounes El Yousfi
Younes El Yousfi
SBSofía Boyero-Corral
Sofía Boyero-Corral
Anna Nardi RicartAnna Nardi Ricart
Anna Nardi Ricart
CSCarlos Suñé
Carlos Suñé
Background: Cationic solid lipid nanoparticles (SLNs) have been given considerable attention for therapeutic nucleic acid delivery owing to their advantages over viral and other nanoparticle delivery systems. However, poor delivery efficiency and complex formulations hinder the clinical translation of SLNs.
Aim:
The aim of this study was to formulate and characterize SLNs incorporating the cholesterol derivative cholesteryl oleate to produce SLN–nucleic acid complexes with reduced cytotoxicity and more efficient cellular uptake. Methods: Five cholesteryl oleate-containing formulations were prepared. Laser diffraction and laser Doppler microelectrophoresis were used to evaluate particle size and zeta potential, respectively. Nanoparticle morphology was analyzed using electron microscopy. Cytotoxicity and cellular uptake of lipoplexes were evaluated using flow cytometry and fluorescence microscopy. The gene inhibition capacity of the lipoplexes was assessed using siRNAs to block constitutive luciferase expression. Results: We obtained nanoparticles with a mean diameter of approximately 150–200 nm in size and zeta potential values of 25–40 mV. SLN formulations with intermediate concentrations of cholesteryl oleate exhibited good stability and spherical structures with no aggregation. No cell toxicity of any reference SLN was observed. Finally, cellular uptake experiments with DNA- and RNA-SLNs were performed to select one reference with superior transient transfection efficiency that significantly decreased gene activity upon siRNA complexation. Conclusion: The results indicate that cholesteryl oleate-loaded SLNs are a safe and effective platform for nonviral nucleic acid delivery.

13 September 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
INIsaac Nofrerias
Isaac Nofrerias
ANAnna Nardi
Anna Nardi
MSMarc Suñé-Pou
Marc Suñé-Pou
JBJoost Boeckmans
Joost Boeckmans
JSJosep Maria Suñé-Negre
Josep Maria Suñé-Negre
MMMontserrat Miñarro-Carmona
Montserrat Miñarro-Carmona
In this study, we suggest optimizing the methodology to determine the Cohesion Index (Icd) in order to avoid mistaken characterizations due to powder bulk density. For this purpose, five different excipients, with different bulk densities and of different chemical nature, were compressed at different heights. Their compression and their tablet characterization enable establishing a powder weight for compression in accordance with its bulk density. Therefore, the resulting tablet will have a height within a defined range of heights where it has no critical effects on its hardness. Then, the impact of this optimization is shown in a formula development, one of the main SeDeM’s applications. A mathematical equation was used to calculate the theoretical amount of excipient to formulate the API according to both methodologies. The compression results demonstrate that the characterization with the NM-Icd is more accurate than the previous one while preserving its simplicity.

27 July 2018
Verified
Preprint
Open access
INIsaac Nofrerias
Isaac Nofrerias
ANAnna Nardi
Anna Nardi
MSMarc Suñé-Pou
Marc Suñé-Pou
JSJosep M. Suñé-Negre
Josep M. Suñé-Negre
EGEncarna García-Montoya
Encarna García-Montoya
MMMontserrat Miñarro
Montserrat Miñarro
This protocol describes the methodology to determine the experimental values of the 12 SeDeM parameters.